Skip to main content
. 2016 Aug 22;7(44):71182–71197. doi: 10.18632/oncotarget.11511

Figure 3. Pharmacologic analysis of hGWL-KinDom and hGWLFL with the AGC kinase inhibitor AT13148.

Figure 3

hGWL-KinDom (•) or immunoprecipitated hGWLFL (☐) was treated with increasing concentrations of AT13148 and kinase activity was measured by either the Kinase-Glo Max (•) or immunoprecipitation kinase assays (☐). Non-linear regression with Prism 6.0 was used to determine IC50 values.